Germany
Japan
United Kingdom
China
Muscle Glycogen Synthase Phospho S641 Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Antibodies
View as table DownloadArhgap22 phospho S22 Antibody
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Arhgap22 phospho S397 Antibody
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
TBC1D4 phospho T642 Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
JAK2 phospho Y372 Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
JAK2 phospho Y972 Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
BLM phospho S1290 Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
BLM phospho S1296 Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
BLM phospho S144 Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Huntington phospho S421 Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Huntington phospho S1181 Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Histone H3 K4me2/phospho T6 Antibody
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | C. elegans, Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit monoclonal to Phospho-Histone H3 (Thr3)
| Applications | ELISA, ICC, IHC, LMNX, WB |
| Reactivities | Human, Vertebrates |
| Conjugation | Unconjugated |
Active filters
Applications
- IHC
Assay Types
- Indirect
Filter by
Category
Target Symbol
- MUC1 (10)
- CD52 (6)
- CD4 (5)
- AOC3 (4)
- CCRL2 (4)
- CD44 (4)
- FN1 (4)
- INSR (4)
- TIMD4 (4)
- TNFRSF8 (4)
- VSIR (4)
- APP (3)
- BLM (3)
- ERBB2 (3)
- ITGA5 (3)
- LEY (3)
- TNF (3)
- TYRP1 (3)
- VEGFA (3)
- AGER (2)
- AKT1 (2)
- ALB (2)
- ARHGAP22 (2)
- CD1A (2)
- CD40 (2)
- CD55 (2)
- CD74 (2)
- CD80 (2)
- CD81 (2)
- CMKLR1 (2)
- DSRNA (2)
- EGFR (2)
- GM2 (2)
- GROUP ANTIGEN (2)
- H3 (2)
- H4 (2)
- HTT (2)
- IGM (2)
- IL10 (2)
- IL16 (2)
- IL4 (2)
- JAK2 (2)
- NOTCH1 (2)
- NTRK1 (2)
- PDCD1 (2)
- RAP (2)
- RHO (2)
- SEPTIN5 (2)
- SNAP25 (2)
- TNFRSF9 (2)
- TP53 (2)
- TSPAN1 (2)
- A2M (1)
- ATP4A (1)
- BRONCHIAL BASEMENT CELLS (1)
- CD200 (1)
- GYS1 (1)
- H3-3A (1)
- HBB (1)
- HIST2H3C (1)
- ITGAM (1)
- LCN2 (1)
- MUC5AC (1)
- MYL12A (1)
- P4HB (1)
- PDCD4 (1)
- PEPC (1)
- PRION (1)
- RETICULAR FIBROBLASTS AND RETICULAR FIBRES (1)
- SIRPA (1)
- STAT5A (1)
- TBC1D4 (1)
Reactivities
- Human (126)
- Mouse (47)
- Rat (22)
- Monkey (10)
- Pig (7)
- Porcine (6)
- Rabbit (6)
- Sheep (6)
- Chimpanzee (5)
- Bovine (4)
- Cow (4)
- Goat (4)
- Primate (4)
- Hamster (3)
- Cynomolgus (2)
- Dengue virus (2)
- Feline (2)
- Guinea Pig (2)
- Virus (2)
- West Nile Virus (2)
- Yellow Fever Virus (2)
- Zebrafish (2)
- C. elegans (1)
- Vertebrates (1)
Antibody Hosts
Isotypes
Clonalities
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (18)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)